disease-prevention

Documents about disease-prevention

• Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS#172392ClinicalTrials.gov
• Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP#290826ClinicalTrials.gov
• Enhancing Non-communicable Disease Prevention and Control Through Parent-Teachers-Development Agents Network in Ethiopia#332821ClinicalTrials.gov
• A Decade of the Center for Disease Control and Prevention's FluSight Influenza Forecasting#343649bioRxiv / medRxiv
• COVID-19#423414Open Library
• Guideline: sodium intake for adults and children#479891WHO IRIS
• A scoping review: Community health workers engagement in mosquito borne disease prevention activities#676212Europe PMC
• TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment#839951ClinicalTrials.gov
• Cleaner Air for Lower Cardiometabolic Risk#846283ClinicalTrials.gov
• Stroke Card Long-term Follow-Up#856121ClinicalTrials.gov
• Theoretically Informed Behavioral Intervention#858366ClinicalTrials.gov
• Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease#882717ClinicalTrials.gov
• Prevention of Cystic Fibrosis Diabetes#901159ClinicalTrials.gov
• Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease#862253ClinicalTrials.gov
• Tuberculosis surveillance and monitoring in Europe 2013: surveillance report#310536WHO IRIS
• Tuberculosis surveillance and monitoring in Europe 2025: 2023 data#317113WHO IRIS
• An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure#806712ClinicalTrials.gov
• Infection prevention and control considerations for routine immunization activities during the Bundibugyo virus disease outbreak: interim guidance, 21 August 2026#484366WHO IRIS
• Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease#877713ClinicalTrials.gov
• RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients#906290ClinicalTrials.gov
• A Clinical Trial for Inactivated Vaccine(Vero Cell) Against EV71 in Chinese Healthy Young Adults and Children#123539ClinicalTrials.gov
• A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants#253064ClinicalTrials.gov
• PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study#633811ClinicalTrials.gov
• VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19#858534ClinicalTrials.gov
• Coronary Artery Calcium-guided Primary Prevention of Major Coronary Heart Disease in Asymptomatic Diabetes#902024ClinicalTrials.gov
• Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease#966101ClinicalTrials.gov
• Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation#968050ClinicalTrials.gov
• Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway#889940ClinicalTrials.gov
• The Role of Polyunsaturated Fatty Acids (PUFAs) in the Primary Prevention of Allergic Diseases in Children: A Position Paper of the SIAIP Primary and Secondary Prevention of Allergic Diseases and Nutraceuticals Committees#482777IRIS
• Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease#881479ClinicalTrials.gov
• Education On Clean and Healthy Living Behavior in Prevention Of Pediculosis Capitis Disease#11385Crossref
• Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)#28437ClinicalTrials.gov
• Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trials.#125279NCBI PubMed Central
• Integrating Cardiology and Public Health: A Review of Population-Based Strategies for Cardiovascular Disease Prevention.#170736NCBI PubMed Central
• Beyond disease treatment and prevention: From geroscience and molecular hallmarks to gerotherapeutics and precision geromedicine.#218834NCBI PubMed Central
• Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines#283107ClinicalTrials.gov
• Broadening sources of finance for health promotion and disease prevention: Smart capacitating investment.#440870NCBI PubMed Central
• Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships#812843ClinicalTrials.gov
• Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand#833859ClinicalTrials.gov
• Effects of Brisk Walking on Overweight/Obesity Population#835580ClinicalTrials.gov
• TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment#839164ClinicalTrials.gov
• MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation#848300ClinicalTrials.gov
• Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents#869591ClinicalTrials.gov
• Danish Cardiovascular Screening Trial II#879290ClinicalTrials.gov
• Ginkgo Biloba Prevention Trial in Older Individuals#884036ClinicalTrials.gov
• HBOT in the Treatment and Prevention of aGVHD#895667ClinicalTrials.gov
• Purdue University Parenting Program Attrition#900623ClinicalTrials.gov
• Dissemination and Implementation of Stroke Prevention Looking at the Care Environment#906221ClinicalTrials.gov
• Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease#967368ClinicalTrials.gov
• Plasma S-adenosylhomocysteine Levels and Endothelial Dysfunction#1032128ClinicalTrials.gov